Sirtex acquires FDA-cleared Hourglass vascular plug for peripheral embolization
Sirtex acquires the FDA-cleared Hourglass vascular plug for peripheral embolization; the FDA approves Wilserdly for ESR1-mutated breast cancer and CMS proposes the CRUSH anti-fraud rule.